Autophagy inhibition in adult-onset Still's disease: still more space for hydroxychloroquine?

Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):133-134. Epub 2017 Oct 23.

Authors

Charalampos Papagoras¹, Akrivi Chrysanthopoulou², Alexandros Mitsios², Athanasios Arampatzioglou², Konstantinos Ritis¹, Panagiotis Skendros³

Affiliations

¹ First Department of Internal Medicine; and Laboratory of Molecular Haematology, Democritus University of Thrace, Alexandroupolis, Greece.
² Laboratory of Molecular Haematology, Democritus University of Thrace, Alexandroupolis, Greece.
³ First Department of Internal Medicine; and Laboratory of Molecular Haematology, Democritus University of Thrace, Alexandroupolis, Greece. pskendro@med.duth.gr.

PMID: 29148405

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antirheumatic Agents / therapeutic use*
Autophagy / drug effects*
Drug Substitution
Extracellular Traps / drug effects
Extracellular Traps / immunology
Female
Humans
Hydroxychloroquine / therapeutic use*
Middle Aged
Neutrophils / drug effects*
Neutrophils / immunology
Neutrophils / pathology
Still's Disease, Adult-Onset / diagnosis
Still's Disease, Adult-Onset / drug therapy*
Still's Disease, Adult-Onset / immunology
Treatment Outcome

Substances

Antirheumatic Agents
Hydroxychloroquine